Myoptechs

Medical Devices & EquipmentSeedColumbus, USmyoptechs.com

Latest round

Seed

Last raised

Aug 2024

Total raised

$1.3M

Investors

2

About Myoptechs

Based in Ohio, US, and founded in 2022, Myoptechs, Inc. is an ophthalmic medical device company offering eye contact lenses that help patients suffering from myopia slow down their progression. As of 2024, the company is headed by its CEO Paul Grimm. The company offers a solution designed to slow the progression of myopia (nearsightedness) while providing clear vision. Myoptechs’ primary offering is a soft contact lens featuring the patent-pending Faceted Optical System™, which is specifically engineered to manage myopia progression. This design aims to provide clearer vision and myopic defocus—an optical signal known to help slow the progression of myopia.

Who invested in Myoptechs

2 investors across 1 round

See all investors in Myoptechs

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Aug 30, 2024

    Amount

    $1.3M

    Investors

    Locked

Questions about Myoptechs

Who invested in Myoptechs?

Myoptechs has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Myoptechs raised?

Myoptechs has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Myoptechs last raise money?

Myoptechs's most recent round on record is a Seed, in Aug 2024.

What does Myoptechs do?

Based in Ohio, US, and founded in 2022, Myoptechs, Inc.

Where is Myoptechs headquartered?

Myoptechs is headquartered in Columbus, US.

Which VCs invest in companies like Myoptechs?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Myoptechs's stage. Their profiles are linked below.

Raising like Myoptechs? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.